We work at the interface between academia and industry

Who We Are

BioMed X Institute – an inspiring collaboration model solving the biggest challenges in biomedical research

BioMed X is an independent research institute located at the campus environment of the University of Heidelberg in Germany. We operate at the interface between academia and industry and perform research in the fields of molecular biology, cell biology, computational biology, and diagnostics.

All our research projects are sponsored by leading pharmaceutical companies and conducted by early-career scientists recruited from the best schools around the world. The combination of global crowdsourcing with local incubation of the best research talents and ideas allows us to solve the biggest challenges in biomedical research.

We stand for free, creative, and curiosity-driven research combined with a solid validation of results, timelines, and deliverables. We serve a large purpose in advancing translational biomedicine by leveraging synergies and fostering cross-pollination across disciplines.

Completed Projects

Completed Projects

Since 2013 we have started 16 research groups and successfully completed 8 projects. After a project term of 5 years all data, materials and intellectual property rights are transferred to the sponsoring partners.

Read more

Scientific Publications

Scientific Publications

For us at BioMed X, publishing the results of our research projects in peer-reviewed journals is key. We also share results at national and international meetings and workshops. We think this is vital to building collaborations and stimulating cross-fertilization of ideas and methods.

Read more

The biomedical research hub at the University of Heidelberg

The biomedical research hub at the University of Heidelberg

We work together on the campus environment of the University of Heidelberg, one of the largest biomedical research hubs in Europe. The BioMed X Institute is hosted by Heidelberg Technology Park together with around 100 small and medium-sized biotech companies.

Read more

Image of

Close